Key Clinical Message:
Rare, aggressive primary vaginal melanoma presents late with bleeding and palpable masses. Histology and immunohistochemistry confirm the diagnosis. Nivolumab and Ipilimumab offer hope in advanced stages. Early diagnosis is critical for better outcomes.